The agency has been reviewing thyroid cancer risk signals, pancreatitis associations, and, more recently, potential psychiatric effects including suicidality, though the evidence for the latter has been largely reassuring in major pharmacovigilance analyses [6]
Approximately 6 days, based on pharmacokinetic data from Eli Lillys Phase 2 clinical trials
Injecting on the same day each week, at roughly the same time, is the most important timing variable
Can I choose my GLP-1 meals
Retatrutide: The Triple Agonist Thats Redrawing the Map of Obesity Medicine Updated with TRIUMPH-1 and TRANSCEND-T2D-1 Phase 3 data presented at the ADA 86th Scientific Sessions (June 2026) The Short Version Retatrutide (LY3437943, Eli Lilly) is an investigational, once-weekly subcutaneous peptide that hits three metabolic receptors at once: GIP, GLP-1, and glucagon
Possible Side Effects The most common GLP-1 side effects are digestive